Myonexus Therapeutics
Myonexus Therapeutics is a clinical stage gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy (LGMD) types 2D, 2B, 2E, 2L, and 2C based on research at Nationwide Children’s Hospital, a leader in muscular dystrophy gene therapy discovery and translational research.
- Website: myonexustx.com
Expert Office Hours
Your Questions • Our Experts
Private Appointments
Fridays, 8:30-11:30 am
| 2022 | 2023 |
|---|---|
| August 5 | February 3 |
| October 7 | April 7 |
| December 2 | June 2 |
Have Expertise?
Subscribe to Our Updates!
Why New Albany?
As a community created by innovators for innovators, New Albany offers a robust ecosystem that leverages entrepreneurship, business connectivity, public-private partnerships and quality of life to inspire creativity and accelerate commerce.